Drug-eluting beads chemoembolization combined with programmed cell death 1 inhibitor and lenvatinib for large hepatocellular carcinoma
D-TACE-P-L may have significantly better PFS and ORR for large HCC, while exhibiting similar AEs to C-TACE-P-L.
Authors
- Jie Liu (ORCID: https://orcid.org/0009-0001-0952-632X)
- Guang-Ping Qiu
- T.-S. Yang (ORCID: https://orcid.org/0009-0001-2488-9532)
- Hui Yang (ORCID: https://orcid.org/0009-0008-9003-1025)
Institutions
- Ningbo No. 2 Hospital (CN)
- Ningbo No.6 Hospital (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2024-10-25
- DOI
- https://doi.org/10.4251/wjgo.v16.i11.4392
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00